There are 0 comments attached to this mailout - Review Comments
If you would like to receive weekly mail digest please Register
OR Forward this mail to a friend
IVFDaily Mail out is about distribution of educational, professional, industry news and product information. If you are a manufacturer or a distributor and wish to make recipients of FertAid Mail aware of your product, please submit a web link here CONTRIBUTE. Listing on IVFdaily.com is Free but inclusion in the mailout attracts a small fee.
From June, 2014 forward, FertAid is developing an online forum for all IVF Clinic Staff. Called IVFClinicMail. When you see this icon against a link, it means there is a comment(s) attached to it. Feel free to click on the icon and contribute.
Jobs
IVFDaily has now provided the tool to advertise any jobs FREE . Simply post the job information as a PDF to office@fertaid.com Listing a position on IVFdaily.com is Free but inclusion in the mailout attracts a small fee.
IVFD
If you receive this distribution by email, then when you click on any link, this linkage will be tagged to your selection list so you can always find it again after you have logged on OR you can click on to mark the link in your file.
A Strength, Weaknesses, Opportunities and Threats analysis on time lapse
Recent findings
Lately, different algorithms have been developed correlating embryo kinetics to blastocyst formation, implantation potential, chromosomal content and live birth rate. Moreover, automation and the use of artificial intelligence have recently been introduced to improve this technology.
Antimullerian hormone is a predictor of live birth in patients with recurrent pregnancy loss
Conclusions: AMH ::< ::1 ::ng/mL is associated with decreased likelihood of live birth among RPL patients pursuing EM, and may be a stronger predictor of live birth than age in this population.
Maternal β:-HCG concentrations in early IVF pregnancy: association with the embryo development stage of blastocysts
Faster-growing blastocysts produced significantly higher serum β:-HCG concentrations 9 days after transfer than slower-growing blastocysts in fresh cycles, but the difference was not significant by day 16 after transfer. Also, β:-HCG concentrations 9 and 16 days after embryo transfer in FET cycles were higher than in fresh embryo transfer cycles. Interpretation of β:-HCG results 9 days after blastocyst transfer should consider the bla
Association of In Vitro Fertilization With Childhood Cancer in the United States
In this population-based cohort study assembled by data linkage, the rate of hepatic tumors was significantly higher among children conceived via IVF than among children conceived naturally (hepatic tumor rate, 18.1 vs 5.7): the rates of other cancers did not differ between the 2 groups. Meaning An association of conception by IVF with childhood cancer is small and limited to rare tumors: however, continued follow-up for cancer occurrence among
Risk of juvenile idiopathic arthritis among children conceived after fertility treatment: a nationwide registry-based cohort study
Our results indicate that fertility treatment per se do not increase the risk of JIA but merely that the increased risk of JIA observed among children born to women with fertility problems may be due to underlying factors related to both infertility and JIA. However, as this is the first large study in this field, further studies are needed to confirm our findings.
Corifollitropin alfa for ovarian stimulation in in vitro fertilization: a systematic review and meta-analysis of randomized controlled trials
Conclusion(s): Corifollitropin alfa seems to be an alternative for daily recombinant FSH injections in normal and poor responder patients undergoing ovarian stimulation in IVF/ICSI treatment cycles.
Deep learning enables robust assessment and selection of human blastocysts after in vitro fertilization
Our analysis shows that the chance of pregnancy based on individual embryos varies from 13.8% (age>40 and poor-quality) to 66.3% (age<37 and good-quality) depending on automated blastocyst quality assessment and patient age. In conclusion, our AI-driven approach provides a reproducible way to assess embryo quality and uncovers new, potentially personalized strategies to select embryos.
Artificial intelligence approach optimizes embryo selection for IVF
A team, consisting of embryologists, reproductive medicine clinicians, computer scientists, and precision medicine experts, trained an artificial intelligence algorithm to discriminate between poor and good embryo quality.
Grandmother gives birth as surrogate for her son and his husband
A 61-year-old woman has given birth to her own granddaughter in the United States after serving as a surrogate for her son and his husband. The woman, Cecile Eledge, from Nebraska, had been through menopause but was nonetheless approved for surrogacy.
Researchers conducted the largest study of childhood cancer after conception by IVF to date. This population-based cohort study had nearly 2.5 times the number of children conceived by IVF than prior studies of the subject in Scandinavia and the United Kingdom.
In-line filter for cylinder and house gasses
O2, N2, CO2, and tri-gas. Aire~LifeLine provides in-line air filtration with top of the line protection, delivering a better and more consistent yield of cylinder and house gasses for a wide range of med
Vit Kit - Warm NX is an adaptable, cost-effective system for use in the thawing of oocytes, pronuclear zygotes, cleavage stage embryos, and blastocyst stage embryos. Unlike many vitrification kits that feature a mono-buffered system and M199 base med
Vit Kit - Freeze NX is an adaptable, cost-effective system for use in the vitrification of oocytes, pronuclear zygotes, cleavage stage embryos, and blastocyst stage embryos. Vit Kit - Freeze NX is the latest advancement in vitrification media aimed t
S-Cryolock is the slimmer version of the original. It is a versatile, simple and efficient vitrification device that is intended for the holding, cryopreservation and storage of oocytes or embryos in liquid nitrogen.
Source
Irvine Scientific
New Developments at FertAid during
May, 2024 and May, 2024
No News
FertAid Functions.
EQA
A range of online Quality Assurance Modules
IVFDaily
New Articles in Press and Interesting, relevant News Items, Business News and other mail
IVFCPD
New education modules
Logbooks
Free Online logbook for IVFLaboratory and Nursing Staff
KPI Benchmarking
New to FertAid. This modules allows ANONYMOUS monthly KPI data entry, management of warning and action limits and anonymous comparisons with country and defined KPI sub-groups
Business
Unlike other mailgroups, IVFDaily will distibute recent business news or developments of interest to IVF staff
to mark the link in your file.
